The US stock market’s gains fell slightly at midday on Monday, and the Nasdaq rose nearly 1.5%. Due to the rise of large technology stocks, AstraZeneca’s new crown vaccine trial in the UK is about to restart. The panic index VIX fell 3.61% to 25.90 points.

As of press time, the Dow rose 321.14 points to 27986.78 points, an increase of 1.16%; the Nasdaq rose 156.37 points to 1,1009.92 points, an increase of 1.44%; the S&P 500 index rose 42.67 points to 3,383.64 points, an increase of 1.28%.

Large technology stocks have risen. Apple rose 1.99%; Facebook rose 3%; Amazon rose 1.82%; Microsoft rose 2.15%; Google rose 2.82%; Netflix fell 0.1%; Tesla rose 7.37%, and its stock price exceeded $400. After the resumption of trading, Oracle has now risen by 4.84%, confirming that it is a participant in the Bytedance/TikTok transaction plan submitted to the US government and will serve as the trusted technology provider of Bytedance. Nvidia rose 5.5% and agreed to acquire British chip designer ARM from SoftBank for $40 billion.

Driven by the good news about vaccines, European stocks fluctuated upward, with the Stoxx Europe 600 index rising 0.1%. As of the close, the Shanghai Composite Index rose 0.57%; the Nikkei 225 index rose 0.65%, and the South Korean KOSPI index rose 1.3%.

Oil prices fell slightly, as demand concerns put the market under pressure. WTI crude oil futures fell 0.81% to 37.027 US dollars per barrel; Brent crude oil futures fell 0.9% to 39.471 US dollars per barrel.

The US dollar index is weak, the market is waiting for the Fed’s meeting on interest rates, and the price of gold rose slightly. The dollar index fell 0.31% to 92.9600. US COMEX gold futures rose 1.2% to US$1971.230 per ounce.

Oxford University-AstraZeneca’s new crown vaccine trial in the UK is about to restart

The University of Oxford and AstraZeneca restarted the new crown vaccine trial in the UK, and the illness of a previous participant in the trial caused worries.

The University of Oxford stated in a statement that after the trial was suspended on September 6 due to the need for independent evaluation of safety data, the UK regulatory agency-the Medical and Health Regulatory Agency (MHRA)-has recommended to restart the trial. The university declined to disclose details of the patient’s condition.

“The British committee has completed its investigation and recommended to MHRA that the British trial can be restarted safely,” AstraZeneca said.

Although it is very common to have a suspension in the vaccine trial stage, the closely watched AstraZeneca-Oxford vaccine research and development has been blocked, which raises concerns about whether this most rapidly progressing experimental vaccine will eventually take shape.

The U.S. House of Representatives resumes, can the epidemic relief plan be passed, facing the last fight

US Treasury Secretary Steven Mnuchin said earlier this month that although the Trump administration and Congress are at a deadlock over funding for the new crown epidemic, both sides agree on one point: it is necessary to introduce a stimulus plan.

However, the two sides did not start serious negotiations on this, and the possibility of reaching a bailout bill before the November general election is also rapidly declining.

Speaker of the House of Representatives Nancy Pelosi will welcome the resumption of the House of Representatives on Monday, but it is unlikely that this will inject new momentum into the discussion. Both Republicans and Democrats are experimenting with high-stakes strategies that believe that the public-and voters-will blame each other for failing to provide help to millions of families and businesses.

As some Republicans’ worries about the deficit have rekindled, and progressive Democrats bet that Trump will be forced to accept the largest stimulus package in history based on the $2 trillion measures implemented in March, leading to negotiations. It was in a stalemate and broke on August 7.

With the resumption of the House of Representatives, Pelosi asked members to unify their strategy, prompting the Republican Party to make new concessions. She insisted to the party that sticking to the $2.2 trillion request would force Trump, who lags behind Biden in polls, to compromise.